Health In Tech director sells 17,730 shares
A Health In Tech, Inc. director reported open-market sales totaling 17,730 Class A Common shares over two days in September 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Health In Tech, Inc. (HIT) reported that director Timothy Hayes sold Class A Common Stock in two recent transactions. On September 11, 2026 he sold 12,000 shares at $0.91 per share, and on September 9, 2026 he sold 5,730 shares at $0.93 per share, for total reported sales of 17,730 shares, all held directly. No Rule 10b5-1 trading plan is reported for these sales, and the filing does not state his remaining shareholdings.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 12,000 | $0.91 | $11K |
| Sale | Class A Common Stock | 5,730 | $0.93 | $5K |
Key Figures
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did HIT report for director Timothy Hayes?
What prices did Timothy Hayes receive for his HIT stock sales?
Were Timothy Hayes’ HIT stock sales made under a Rule 10b5-1 trading plan?
What is Timothy Hayes’ role at Health In Tech, Inc. (HIT)?
AI-generated analysis. How Rhea-AI works. Not financial advice.